Preview

Rational Pharmacotherapy in Cardiology

Advanced search

RECENT ASPECTS OF CARDIAC REMODELING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

https://doi.org/10.20996/1819-6446-2018-14-3-379-386

Full Text:

Abstract

The paper aimed to present evidence of the effect of some pathophysiological features of chronic obstructive pulmonary disease (COPD) on cardiac remodeling in patients free of overt cardiovascular diseases, traditional cardiovascular risk factors and pulmonary hypertension. Contrary to traditional beliefs that cardiac abnormalities in COPD have been mainly associated with the right ventricle, several recent studies have shown an independent effect of pulmonary hyperinflation and emphysema on left ventricular (LV) diastolic filling and LV hypertrophy. Pulmonary hyperinflation and emphysema cause intrathoracic hypovolemia, low preload, small end-diastolic dimension and mechanical compression of LV chamber which could worsen end-diastolic stiffness. Interestingly, that the presence of LV hypertrophy in COPD patients is important but currently poorly understood area of investigation. Pulmonary hyperinflation, increased arterial stiffness and sympathetic activation may be associated with LV hypertrophy. Two-dimensional ultrasound speckle tracking studies have shown the presence of sub-clinical LV systolic dysfunction in patients even with moderate COPD and free of overt cardiovascular diseases. Sarcopenia related to the inflammatory-catabolic state in COPD and hypoxia could play an important role regarding LV systolic dysfunction. Recent data reported the effects of long-acting bronchodilators on reducing lung hyperinflation (inducing lung deflation). Further studies are required to evaluate the effects of pharmacological lung deflation therapy on cardiac volume and function.

About the Authors

V. V. Lee
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

MD, PhD, Professor, Chair of Polyclinic Therapy,

Delegatskaya ul. 20/1, Moscow, 127473



N. Yu. Timofeeva
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

MD, PhD, Associate Professor, Chair of Polyclinic Therapy,

Delegatskaya ul. 20/1, Moscow, 127473



V. S. Zadionchenko
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

MD, PhD, Professor, Chair of Polyclinic Therapy,

Delegatskaya ul. 20/1, Moscow, 127473



T. V. Adasheva
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

MD, PhD, Professor, Chair of Polyclinic Therapy,

Delegatskaya ul. 20/1, Moscow, 127473



N. V. Vysotskaya
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation

MD, Post-Graduate Student, Chair of Polyclinic Therapy,

Delegatskaya ul. 20/1, Moscow, 127473



References

1. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165- 85. doi: 10.118309031936.00128008.

2. Watz H., Waschki B., Meyer T. et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138(1):32-8. doi: 10.1378/chest.09-2810.

3. Sabit R., Bolton C.E., Fraser A.G. et al. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med. 2010;104:1171-8. doi:10.1016/j.rmed.2010.01.020.

4. Barr R.G., Bluemke D.A., Ahmed F.S. et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362(3):217-27.doi:10.1056/NEJMoa0808836.

5. Smith B.M., Prince M.R., Hoffman E.A. et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs?: the multi-ethnic study of atherosclerosis COPD study. Chest. 2013;144(4):1143-51. doi: 10.1378/chest.13-0183.

6. Smith B.M., Kawut S.M., Bluemke D.A. et al. Pulmonary hyperinflation and left ventricular mass: The Multi-Ethnic Study of atherosclerosis COPD Study. Circulation. 2013;127:1503-11. doi: 10.1161/CIRCULATIONAHA.113.001653/-/DC1.

7. Gabinski C., Courty G., Besse P., Castaing R. Left ventricular function in chronic obstructive lung disease. Bull Eur Physiopath Resp. 1979;15:755-72.

8. Gomez A., Unruh H., Mink S.H. Altered left ventricular chamber stiffness and isovolumic relaxation in dogs with chronic pulmonary hypertension caused by emphysema. Circulation. 1993;87:247-260.

9. Boussuges A., Pinet C., Molenat F. et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J RespirCrit Care Med. 2000;162:670- 5. doi:10.1164/ajrccm.162.2.9908056.

10. Funk G.С, Lang I., Schenk P. et al. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest. 2008;133:1354-9. doi:10.1378/chest.07-2685.

11. Lopez-Sanchez M., Munos-Escquerre M., Huertas D. et al. High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study. PLoS ONE. 2013;8(6):e68034. doi:10.1371/journal.pone.0068034.

12. Schoos M.M., Dalsgaard M., Kjærgaard J. et al. Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovasc Disord. 2013;13:84. doi: 10.1186/1471-2261-13-84.

13. MacNee W., Maclay J.D., McAllister D.A. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:824-33. doi: 10.1513/pats.200807-071TH.

14. Maclay J.D., McAllister D.A., Johnston S. et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax. 2011;66:769-74. doi: 10.1136/thx.2010.157529.

15. Mills N.L., Miller J.J., Anand A. et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63:306-11. doi: 10.1136/thx.2007.083493.

16. Bhattacharyya P., Acharjee D., Ray S. et al. Left ventricular diastolic dysfunction in COPD may manifest myocardial ischemia. COPD. 2012;9(3):305-9. doi: 10.3109/15412555.2012.661805.

17. Maclay J.D., MacNee W. Cardiovascular disease in COPD: mechanisms. Chest. 2013;143:798-807. doi: 10.1378/chest.12-0938.

18. Cuttica M.J., Kalhan R., Shlobin O.A. et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877-82. doi: 10.1016/j.med.2010.05.009.

19. Cuttica M.J., Shah S.J., Rosenberg S.J. et al. Right heart structural changes are independently associated with exercise capacity in non-severe COPD. PLoS ONE. 2011;6(12):e29069. doi:10.1371/journal.pone.0029069.

20. Wigh R.E. On defining microcardia: application in pulmonary emphysema. South Med J. 1978;71(2):150-4.

21. Jörgensen K., Houltz E., Westfelt U. et al. Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest. 2003;124(5):1863-70. doi: 10.1378/chest.124.5.1863.

22. Jörgensen K., Muller M. F., Nel J. et al. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest. 2007;131(4):1050- 7. doi: 10.1378/chest.06-2245.

23. Watz H., Waschki B., Boehme C. et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J RespirCrit Care Med. 2008;177(7):743-51. doi: 10.1164/rccm.200707-10110C.

24. O’Donnel D.E. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(2):180-4. doi: 10.1513/pats.200508-093DO.

25. Vassaux C., Torre-Bouscoulet L., Zeineldine S. et al. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J. 2008;32:1275-82. doi: 10.1193/09031936.00151707.

26. Tzani P., Aiello M., Elia D. et al. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res. 2011;12:150. doi:10/1186/1465-9921-12-150.

27. Avdeev S.N. Pulmonary hyperinflation in COPD patients. Atmosphera. Pulmonologya I Allegrologya. 2006;2:11-6. (In Russ.) [Авдеев С.Н. Легочная гиперинфляция у больных ХОБЛ. АтмосферА. Пульмонология и Аллергология. 2006;2:11-6].

28. Lammi M.R., Ciccolella D., Marchetti N. et al. Increased oxygen pulse after lung volumereduction surgery is associated with reduce dynamic hyperinflation. Eur Respir J. 2012;40:837-43. doi: 10.1183/09031936.00169311

29. Kohama A., Tanouchi J., Hori M. et al. Pathologic involvement of the left ventricle in chronic cor pulmonale. Chest. 1990;98:794-800. doi: 10.1378/chest.98.4.794.

30. Baum G.L., Schwartz A., Llamas R. et al. Left ventricular function in chronic obstructive lung disease. N Engl J Med. 1971;285:361-5.

31. McAllister D.A., Maclay J.D., Mills N.L. et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:1208-14. doi: 10.1164/rccm.200707-1080OC.

32. Anderson W.J., Lipworth B.J., Rekhraj S. et al. Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? Chest. 2013;143:91-7. doi: 10.1378/chest.12-0775.

33. Burgel P.R., Paillasseur J.L., Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int. 2014;2014:420134. doi: 10.1155/2014/420134

34. Teopompi E., Panagioya T., Aiello M. et al. Fat free mass depletion is associated to poor exercise capacity irrespective of dynamic hyperinflation in COPD patients. Respir Care. 2014;59:718-25. doi: 10.4187/respcare.02709.

35. Bolton C.E., Ionescu A.A., Shiels K.M. et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(12):1286-93. doi: 10.1164/rccm.200406-754OC.

36. Stone I.S., Barnes N.C., James W-Y et al. Lung deflation and cardiovascular structure and function in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015;193(7):717-26. doi: 10.1164/rccm.201508-1647OC.


For citation:


Lee V.V., Timofeeva N.Y., Zadionchenko V.S., Adasheva T.V., Vysotskaya N.V. RECENT ASPECTS OF CARDIAC REMODELING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Rational Pharmacotherapy in Cardiology. 2018;14(3):379-386. (In Russ.) https://doi.org/10.20996/1819-6446-2018-14-3-379-386

Views: 168


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)